NASDAQ: RXRX - Recursion Pharmaceuticals, Inc.

Rentabilidad a seis meses: +13.67%
Rendimiento de dividendos: 0.00%
Sector: Healthcare

Calendario de promoción Recursion Pharmaceuticals, Inc.

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. работает как биотехнологическая компания на клинической стадии, расшифровывающая биологию путем интеграции технологических инноваций в области биологии, химии, автоматизации, науки о данных и инженерии для индустриализации открытия лекарств. В нем есть четыре кандидата на клинические препараты, предназначенные для лечения редких моногенных заболеваний; и 33 дополнительных программы на разных стадиях доклинической разработки. Recursion Pharmaceuticals, Inc. имеет стратегические соглашения с Bayer; Государственный инновационный фонд Огайо; Chromaderm, Inc .

más detalles
; и Takeda Pharmaceutical Company Limited. Компания была основана в 2013 году и базируется в Солт-Лейк-Сити, штат Юта.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

IPO date 2021-04-16
ISIN US75629V1044
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.recursion.com
Цена ао 8.28
Cambio de precio por día: +1.66% (8.14)
Cambio de precio por semana.: -23.87% (10.87)
Cambio de precio por mes: +17.71% (7.03)
Cambio de precio en 3 meses.: +29.7% (6.38)
Cambio de precio en seis meses: +13.67% (7.28)
Cambio de precio por año: -36.05% (12.94)
Cambio de precio en 3 años.: +19.24% (6.94)
Cambio de precio en 5 años.: 0% (8.275)
Cambio de precio en 10 años.: 0% (8.275)
Cambio de precio desde principios de año.: +33.15% (6.215)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 50.31 1
P/BV 4.84 3
P/E 0 0
EV/EBITDA -5.98 0
Total: 3.25

Eficiencia

Nombre Significado Calificación
ROA, % -50.19 0
ROE, % -70.79 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0

Deber

Nombre Significado Calificación
Debt/EBITDA -0.0229 10
Total: 9.6

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 2128.75 10
Rentabilidad Ebitda, % 419.17 10
Rentabilidad EPS, % 186.97 10
Total: 10
Más detalles

Fecha de transacción fecha de divulgación Persona enterada Tipo Precio Volumen Cantidad Comparte hasta, % compartir después, % Documento
14.11.2024 15.11.2024 Gibson Christopher
Chief Executive Officer		 Venta 7.35 147 000 20000 0 -0.01 enlace
13.11.2024 15.11.2024 Gibson Christopher
Chief Executive Officer		 Venta 7.74 154 800 20000 0 -0.01 enlace
27.08.2024 27.08.2024 Gibson Christopher
Chief Executive Officer		 Compra 2.48 12 400 5000 0 0 enlace
23.07.2024 25.07.2024 Borgeson Blake
Director		 Venta 8.48 97 071 11447 0 -0.01 enlace
27.06.2024 28.06.2024 Marriott Tina
President and COO		 Venta 7.21 43 260 6000 0 0 enlace
27.06.2024 28.06.2024 Marriott Tina
President and COO		 Compra 1.06 6 360 6000 0 0 enlace
25.06.2024 27.06.2024 Borgeson Blake
Director		 Venta 9.51 108 861 11447 0 -0.01 enlace
06.06.2024 07.06.2024 Gibson Christopher
Chief Executive Officer		 Venta 9 450 000 50000 0 -0.03 enlace
05.06.2024 07.06.2024 Gibson Christopher
Chief Executive Officer		 Venta 8.42 421 000 50000 0 -0.03 enlace
17.04.2024 18.04.2024 Secora Michael
Chief Financial Officer		 Venta 7.58 175 280 23124 0 -0.01 enlace
17.04.2024 18.04.2024 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
16.04.2024 18.04.2024 Secora Michael
Chief Financial Officer		 Venta 7.67 191 750 25000 0 -0.02 enlace
16.04.2024 18.04.2024 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
16.04.2024 18.04.2024 Borgeson Blake
Director		 Venta 7.66 87 684 11447 0 -0.01 enlace
13.03.2024 14.03.2024 Secora Michael
Chief Financial Officer		 Venta 11.03 275 750 25000 0 -0.02 enlace
13.03.2024 14.03.2024 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
12.03.2024 14.03.2024 Secora Michael
Chief Financial Officer		 Venta 10.46 261 500 25000 0 -0.02 enlace
12.03.2024 14.03.2024 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
20.02.2024 21.02.2024 Borgeson Blake
Director		 Venta 12.32 247 065 20054 0 -0.01 enlace
14.02.2024 15.02.2024 Secora Michael
Chief Financial Officer		 Venta 10.46 261 500 25000 0 -0.02 enlace
14.02.2024 15.02.2024 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
13.02.2024 15.02.2024 Secora Michael
Chief Financial Officer		 Venta 9.86 246 500 25000 0 -0.02 enlace
13.02.2024 15.02.2024 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
06.02.2024 08.02.2024 Borgeson Blake
Director		 Venta 9.3 106 457 11447 0 -0.01 enlace
25.01.2024 29.01.2024 Larson Tina Marriott
President and COO		 Venta 10.35 82 800 8000 0 -0.01 enlace
25.01.2024 29.01.2024 Larson Tina Marriott
President and COO		 Compra 1.06 8 480 8000 0 0.01 enlace
23.01.2024 25.01.2024 Borgeson Blake
Director		 Venta 10.58 212 171 20054 0 -0.01 enlace
09.01.2024 11.01.2024 Borgeson Blake
Director		 Venta 13.62 273 135 20054 0 -0.01 enlace
09.01.2024 11.01.2024 Li Dean Y
Director		 Venta 13.66 396 140 29000 0 -0.02 enlace
03.01.2024 05.01.2024 Gibson Christopher
Chief Executive Officer		 Venta 9.51 237 750 25000 0 -0.02 enlace
03.01.2024 05.01.2024 Gibson Christopher
Chief Executive Officer		 Venta 9.49 292 795 30853 0 -0.02 enlace
03.01.2024 05.01.2024 Gibson Christopher
Chief Executive Officer		 Compra 2.48 77 500 31250 0 0.02 enlace
05.09.2023 07.09.2023 Borgeson Blake
Director		 Venta 8.79 78 099 8885 0 -0.01 enlace
19.07.2023 19.07.2023 Secora Michael
Chief Financial Officer		 Venta 15.53 388 250 25000 0 -0.02 enlace
19.07.2023 19.07.2023 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
18.07.2023 19.07.2023 Virani Shafique
Chief Business Officer		 Venta 13.74 412 200 30000 0 -0.02 enlace
18.07.2023 19.07.2023 Virani Shafique
Chief Business Officer		 Compra 2.22 66 600 30000 0 0.02 enlace
18.07.2023 19.07.2023 Secora Michael
Chief Financial Officer		 Venta 13.63 340 750 25000 0 -0.02 enlace
18.07.2023 19.07.2023 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
17.07.2023 19.07.2023 Virani Shafique
Chief Business Officer		 Venta 11.72 351 600 30000 0 -0.02 enlace
17.07.2023 19.07.2023 Virani Shafique
Chief Business Officer		 Compra 2.22 66 600 30000 0 0.02 enlace
14.06.2023 15.06.2023 Secora Michael
Chief Financial Officer		 Venta 10.07 251 750 25000 0 -0.02 enlace
14.06.2023 15.06.2023 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
13.06.2023 15.06.2023 Secora Michael
Chief Financial Officer		 Venta 9.93 248 250 25000 0 -0.02 enlace
13.06.2023 15.06.2023 Secora Michael
Chief Financial Officer		 Compra 2.22 83 250 37500 0 0.02 enlace
13.06.2023 15.06.2023 Borgeson Blake
Director		 Venta 9.98 154 540 15485 0 -0.01 enlace
06.04.2023 07.04.2023 Gibson Christopher
Chief Executive Officer		 Venta 6.64 265 600 40000 0 -0.03 enlace
05.04.2023 07.04.2023 Gibson Christopher
Chief Executive Officer		 Venta 6.46 86 092 13327 0 -0.01 enlace
21.03.2023 23.03.2023 Borgeson Blake
Director		 Venta 7.4 65 749 8885 0 -0.01 enlace
02.03.2023 06.03.2023 Gibson Christopher
Chief Executive Officer		 Venta 7.91 19 775 2500 0 0 enlace
02.03.2023 06.03.2023 Gibson Christopher
Chief Executive Officer		 Venta 7.92 146 520 18500 0 -0.01 enlace
24.01.2023 26.01.2023 Borgeson Blake
Director		 Venta 8.71 77 388 8885 0 -0.01 enlace
05.01.2023 06.01.2023 Gibson Christopher
Chief Executive Officer		 Venta 7.38 18 450 2500 0 0 enlace
05.01.2023 06.01.2023 Gibson Christopher
Chief Executive Officer		 Venta 7.39 136 715 18500 0 -0.01 enlace
01.12.2022 02.12.2022 Gibson Christopher
Chief Executive Officer		 Venta 9.27 23 175 2500 0 0 enlace
01.12.2022 02.12.2022 Gibson Christopher
Chief Executive Officer		 Venta 9.02 335 634 37210 0 -0.02 enlace
01.12.2022 02.12.2022 Gibson Christopher
Chief Executive Officer		 Compra 2.48 77 500 31250 0 0.02 enlace
14.10.2022 18.10.2022 Virani Shafique
Chief Business Officer		 Venta 10.92 109 200 10000 0 -0.01 enlace
14.10.2022 18.10.2022 Virani Shafique
Chief Business Officer		 Compra 2.22 11 100 5000 0 0 enlace
06.10.2022 07.10.2022 Gibson Christopher
Chief Executive Officer		 Venta 11.64 29 100 2500 0 0 enlace
06.10.2022 07.10.2022 Gibson Christopher
Chief Executive Officer		 Venta 11.58 417 494 36053 0 -0.02 enlace
06.10.2022 07.10.2022 Gibson Christopher
Chief Executive Officer		 Compra 2.48 77 500 31250 0 0.02 enlace
29.09.2022 03.10.2022 Larson Tina Marriott
President and COO		 Venta 10.86 173 760 16000 0 -0.01 enlace
29.09.2022 03.10.2022 Larson Tina Marriott
President and COO		 Compra 1.06 16 960 16000 0 0.01 enlace
01.09.2022 02.09.2022 Gibson Christopher
Chief Executive Officer		 Venta 10.5 26 250 2500 0 0 enlace
01.09.2022 02.09.2022 Gibson Christopher
Chief Executive Officer		 Venta 10.34 378 092 36566 0 -0.02 enlace
01.09.2022 02.09.2022 Gibson Christopher
Chief Executive Officer		 Compra 2.48 77 500 31250 0 0.02 enlace
04.08.2022 05.08.2022 Gibson Christopher
Chief Executive Officer		 Venta 9.45 23 625 2500 0 0 enlace
04.08.2022 05.08.2022 Gibson Christopher
Chief Executive Officer		 Venta 9.49 349 469 36825 0 -0.02 enlace
04.08.2022 05.08.2022 Gibson Christopher
Chief Executive Officer		 Compra 2.48 77 500 31250 0 0.02 enlace
08.04.2022 12.04.2022 Gibson Christopher
Chief Executive Officer		 Compra 2.48 109 145 44010 0 0.03 enlace
08.04.2022 12.04.2022 Gibson Christopher
Chief Executive Officer		 Venta 6.71 16 775 2500 0 0 enlace
08.04.2022 12.04.2022 Gibson Christopher
Chief Executive Officer		 Venta 6.59 243 303 36920 0 -0.02 enlace
07.04.2022 11.04.2022 Gibson Christopher
Chief Executive Officer		 Venta 6.51 16 275 2500 0 0 enlace
07.04.2022 11.04.2022 Gibson Christopher
Chief Executive Officer		 Venta 6.54 240 136 36718 0 -0.02 enlace
07.04.2022 11.04.2022 Gibson Christopher
Chief Executive Officer		 Compra 2.48 109 145 44010 0 0.03 enlace
06.04.2022 08.04.2022 Gibson Christopher
Chief Executive Officer		 Venta 6.56 16 400 2500 0 0 enlace
06.04.2022 08.04.2022 Gibson Christopher
Chief Executive Officer		 Venta 6.77 242 542 35826 0 -0.02 enlace
06.04.2022 08.04.2022 Gibson Christopher
Chief Executive Officer		 Compra 2.48 109 145 44010 0 0.03 enlace
14.01.2022 14.01.2022 Gibson Christopher
Chief Executive Officer		 Venta 13.57 3 446 780 254000 0 -0.16 enlace
13.01.2022 14.01.2022 Gibson Christopher
Chief Executive Officer		 Venta 14.33 1 246 710 87000 0 -0.06 enlace
16.12.2021 20.12.2021 Larson Tina Marriott
President and COO		 Venta 18.74 46 850 2500 0 0 enlace
09.12.2021 10.12.2021 Gibson Christopher
Chief Executive Officer		 Venta 20.01 21 731 1086 0 0 enlace
08.12.2021 10.12.2021 Gibson Christopher
Chief Executive Officer		 Venta 20.15 214 880 10664 0 -0.01 enlace
08.12.2021 10.12.2021 Gibson Christopher
Chief Executive Officer		 Compra 2.47 70 756 28646 0 0.02 enlace

Instituciones Volumen Compartir, %
Baillie Gifford and Company 24179504 10.65
ARK Investment Management, LLC 20654287 9.09
Vanguard Group Inc 15665210 6.9
Mubadala Investment Co PJSC 12985927 5.72
Blackrock Inc. 12393872 5.46
State Street Corporation 12151646 5.35
FMR, LLC 10897287 4.8
Kinnevik AB (publ) 10405668 4.58
Sumitomo Mitsui Trust Holdings, Inc. 9203780 4.05
Nikko Asset Management Americas, Inc. 9203780 4.05

ETF Compartir, % Rentabilidad del año, % Dividendos, %
ARK Genomic Revolution ETF 6.45616 -8.08 0.05494
ARK Innovation ETF 2.39795 34.1 0.00666
Range Cancer Therapeutics ETF 0.87613 47.24 0.11955
WisdomTree Artificial Intelligence and Innovation Fund 0.77027 16.27 0.58091
Virtus LifeSci Biotech Clinical Trials ETF 0.57046 63.04 0.33
Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund 0.5614 1.54 0.22433
Direxion Daily S&P Biotech Bull 3x Shares 0.23168 4067.92 0.25924
Future Tech ETF 0.18148 426.34 0.8416
Principal Healthcare Innovators ETF 0.18148 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.15403 28.58 0.8565
Nuveen ESG Small-Cap ETF 0.12757 13.91 1.41019
iShares Russell 2000 Growth ETF 0.11979 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.11 23.05 0.60264
ProShares Ultra Nasdaq Biotechnology 0.10573 51.7 0.85651
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.09519 24.75 1.59225
BNY Mellon US Small Cap Core Equity ETF 0.06369 30.07 1.75333
iShares Morningstar Small-Cap Growth ETF 0.06084 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.06084 587.89 0.72598
Vanguard Russell 2000 ETF 0.06 17.16 1.48801
SPDR S&P Kensho New Economies Composite ETF 0.05086 21.57 0.88486
iShares ESG Aware MSCI USA Small-Cap ETF 0.04563 18.09 1.49366
Schwab U.S. Small-Cap ETF 0.03694 17.47 1.51433
iShares Morningstar Small-Cap ETF 0.03054 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.03054 391.25 1.60498
ProShares UltraPro Russell2000 0.03037 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.01837 3 1.46057
Humankind US Stock ETF 0.00916 18.81 1.99919
ProShares Hedge Replication ETF 0.00872 5.92 1.47892
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.00688 17.58 1.75869
Dimensional U.S. Core Equity 2 ETF 0.00677 30.76 1.47098
FlexShares Morningstar US Market Factor Tilt Index Fund 0.0047 21.94 1.69572
SPDR Portfolio MSCI Global Stock Market ETF 0.0034 17.99 2.19607
iShares Russell 3000 ETF 0.00252 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00229 24.86 1.43354
Dimensional US Core Equity Market ETF 0.00192 30.98 1.40618
Dimensional U.S. Equity ETF 0.00153 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817
Vanguard ESG U.S. Stock ETF 0 23.54 1.26927



Supervisor Título profesional Pago año de nacimiento
Ms. Tina Marriott Larson COO & President 612.69k 1975 (50 años)
Dr. Blake C. Borgeson Ph.D. Co-Founder & Director 40k 1982 (43 año)
Dr. Michael Secora Ph.D. Chief Financial Officer 524.19k 1983 (42 año)
Mr. Benjamin Mabey M.S. Chief Technology Officer N/A 1983 (42 año)
Dr. Christopher C. Gibson Ph.D. Co-Founder, CEO & Director 695.18k 1983 (42 año)
Kevin Leggat Vice President of Finance & Accounting N/A
Mr. Jared Allenbach Senior Director of Investor Relations N/A
Mr. Ryan Kelly Chief Communications Officer N/A
Mr. Nathan Hatfield Chief Legal Officer & General Counsel N/A
Dr. David J. Mauro M.D., Ph.D. Chief Medical Officer 1965 (60 años)

DIRECCIÓN: United States, Salt Lake City, UT , 41 South Rio Grande Street - abrir en mapas de google, abrir mapas de Yandex
Sitio web: http://www.recursion.com